Prof. Doron Steinberg, a researcher and lecturer from the Faculty of Dental Medicine and the Director of the Biofilm Research Lab, says that modern microbiology is not designed to kill viruses but rather to attack the biofilm construction. In his lab, basic research is combined with clinical applications for a variety of developments and innovations to help combat biofilm as a major cause for infectious diseases like fungal diseases and Cystic Fibrosis that he is currently researching. “My goal is to think of additional applicable applications for cannabinoids, and the possibilities are endless.” Read more about Is Cannabis the Antibiotics of the 21st Century?
In recent years, the use of medical cannabis to treat sick kids is on the rise, although questions remain about the benefits and safety of such treatments. Now, a team of researchers from the Hebrew University of Jerusalem (HU) has completed a first-ever meta-analysis of pediatric patients treated with medical cannabis to better understand the risks and benefits of cannabis use among young patients Read more about Understanding the Impact of Medical Marijuana on Children, a Meta-Analysis / Ilan Matok
Avi Priel & Masha Niv - Towards novel migraine drugs: activation of the pain receptor TRPA1 by cannabinoids
Joseph Tam, Amiram Goldblum & Yuval Tabach - Discovery and Experimental Confirmation of Novel (Dual-Targeted) Peripherally Restricted CB1 Receptor Antagonists
The 2017 Israel Medical Convention will focus on medical cannabis. Prof. Raphael Mechoulam, Head of the MCCR Academic Committee, will give a lecture on the past and future of cannabis.
Jerusalem, July 26, 2017 — The International Cannabinoid Research Society (ICRS - http://icrs.co) has chosen the Hebrew University of Jerusalem to host the International Symposium on the Cannabinoids in 2021 in Jerusalem.
